Pre-clinical models of infectious diseases - task areas a, b, c, and d
Active Awarded Last action
- Contract number
- 75N93024D00042
- Awardee
-
University Of Texas Medical Branch At Galveston UEI MSPWVMXXMN76
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $8,686,322 obligated
Award facts
- Opportunity
-
- Pre-Clinical Models of Infectious Diseases Pre-Solicitation · NIHAI75N93023R00003 · Posted Oct 21, 2022
- Combined order value
-
- $8,686,322 Current, with exercised options
- $26,271,101 Potential, with all options
- Last date to order 33% complete
- IDV ceiling 6% used
- $146,300,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 76 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to University Of Texas Medical Branch At Galveston on July 15, 2024, with a ceiling value of $146.3 million and a single-award structure. The IDIQ addresses pre-clinical models of infectious diseases across task areas A, B, C, and D, with an ultimate completion date of July 14, 2031.
Place of performance is Galveston, Texas. The originating solicitation, posted October 21, 2022, sought preclinical testing services spanning small animal models, non-human primate models, alternative animal models, and specialized reagent generation supporting medical countermeasure development against emerging pathogens.
Recent task-order activity under this IDIQ includes a $6.285 million delivery order issued July 27, 2026, for screening candidate countermeasures for viral hemorrhagic fever using liver-based organ-on-a-chip microphysiological systems (completion July 26, 2027); a $3.65 million order issued September 15, 2025, for mouse and guinea pig models supporting cytomegalovirus and herpes simplex virus research (completion September 14, 2026); a $5.13 million order issued September 20, 2024, for development of a small animal Lassa virus infection model to assess antiviral activity (completion February 17, 2027); and a $174,528 firm fixed-price order issued August 30, 2024, to extract historical raw data from studies performed under previous IDIQ mechanisms (completion July 14, 2031). All task orders are priced on a cost-no-fee basis with no set-asides applied.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93024D00042?
75N93024D00042 was awarded to University Of Texas Medical Branch At Galveston by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 15, 2024.
How much is contract 75N93024D00042 worth?
Orders under 75N93024D00042 have obligated $8,686,322. Their combined potential value, with all options, is $26,271,101. 75N93024D00042's own ceiling is $146,300,000.
How many orders have been placed under contract 75N93024D00042?
6 orders have been placed under 75N93024D00042, the latest on September 15, 2026.
Who can order from contract 75N93024D00042?
75N93024D00042 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93024D00042 part of a contract vehicle?
Yes. 75N93024D00042 is part of Pre-Clinical Models of Infectious Diseases.
Was contract 75N93024D00042 competed?
The extent of competition for 75N93024D00042 was full and open competition. The government received 76 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV